Study on helioclimate therapy in the high mountains for fungoides
H. Tippel, R. Engst
August 1986
Climate treatment
Skin / Allergies
The effectiveness of topical steroids, chemotherapy, photochemotherapy, borderline radiotherapy and electron beam therapy has already been demonstrated in the treatment of mycosis fungoides. In addition, the results of dermatological climatotherapy in the high Alps region (Davos, 1,560 m) show that natural sunlight exposure in this special climate is very effective in the treatment of mycosis fungoides.
Overall, 63% of 128 treatment cycles in 84 patients with mycosis fungoides went into remission, which lasted at least 13 months. The best results were achieved in the early stages of mycosis fungoides and when climatotherapy was carried out long enough and repeated.
The most important information on the study at a glance
- Indications
- Mycosis fungoides
- Institution
- Clinic and Polyclinic for Dermatology and Allergology, Technical University of Munich, Munich, Germany
- Title
- Study on helioclimate therapy in the high mountains for mycosis fungoides
- Brief description
- The study shows that climatotherapy in the high Alps achieves high remission rates in mycosis fungoides, especially in the early stages.
- Original title
- Mycosis fungoides. Results of helioclimate therapy in high mountains (Davos, 1,560)
- Link to the study
- https://pubmed.ncbi.nlm.nih.gov/3759452/
Suitable trips for this study topic
You might also be interested in
Climate treatment
Respiratory system / Asthma
V. A. Berezovskiĭ et al.
December 1990
The study shows: High mountain climate treatment improves lung capacity, respiratory rate and lung ventilation in bronchitis.
Climate treatment
Respiratory system / Asthma
A. N. Aleksandrov et al.
April 2008
The study shows: Haloinhalation therapy achieves positive effects in allergic and vasomotor rhinitis patients.
Climate treatment
Respiratory system / Asthma
Anna Kubincová et al.
September 2018
The study shows: High-altitude climate therapy improves lung function, physical performance, dyspnea and quality of life in COPD and CB.